Botulinum Toxin Type A Immune Globulin from Germany
Antitoxin derived from human plasma fractions containing antibodies against botulinum toxin, used to treat infant botulism. Classified in HTS 3002.12.0090 as an immunological blood fraction for therapeutic neutralization of toxins. It involves biotech purification of specific antisera.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Include potency assay results (IU/mg) and neutralization efficacy data for CBP clearance
• Ship frozen (-20°C) with chain-of-custody logs to prevent denaturation
• Differentiate from cosmetic botox; declare therapeutic end-use to stay in 3002.12